Abstract
Endogenous prenylation with sesquiterpene or diterpene isoprenoids facilitates membrane localization and functional activation of small monomeric GTP-binding proteins. A direct effect of isoprenoids on regulation of gene expression and protein stability has also been proposed. In this study, we determined the role of sesquiterpene or diterpene isoprenoids on the regulation of Rho G-protein expression, activation, and stability in human trabecular meshwork (TM) cells. In both primary and transformed human TM cells, limiting endogenous isoprenoid synthesis with lovastatin, a potent HMG-CoA reductase inhibitor, elicited marked increases in RhoA and RhoB mRNA and protein content. The effect of lovastatin was dose-dependent with newly synthesized inactive protein accumulating in the cytosol. Supplementation with geranylgeranyl pyrophosphate (GGPP) prevented, while inhibition of geranylgeranyl transferase-I mimicked, the effects of lovastatin on RhoA and RhoB protein content. Similarly, lovastatin-dependent increases in RhoA and RhoB mRNA expression were mimicked by geranylgeranyl transferase-I inhibition. Interestingly, GGPP supplementation selectively promoted the degradation of newly synthesized Rho proteins which was mediated, in part, through the 20S proteasome. Functionally, GGPP supplementation prevented lovastatin-dependent decreases in actin stress fiber organization while selectively facilitating the subcellular redistribution of accumulated Rho proteins from the cytosol to the membrane and increasing RhoA activation. Post-translational prenylation with geranylgeranyl diterpenes selectively facilitates the expression, membrane translocation, functional activation, and turnover of newly synthesized Rho proteins. Geranylgeranyl prenylation represents a novel mechanism by which active Rho proteins are targeted to the 20S proteasome for degradation in human TM cells.
Similar content being viewed by others
References
Holstein SA, Hohl RJ (2004) Isoprenoids: remarkable diversity of form and function. Lipids 39:293–309
Zhang FL, Casey PJ (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65:241–269
Zhang L, Tschantz WR, Casey PJ (1997) Isolation and characterization of a prenylcysteine lyase from bovine brain. J Biol Chem 272:23354–23359
Gao J, Liao J, Yang GY (2009) CAAX-box protein, prenylation process and carcinogenesis. Am J Transl Res 1:312–325
Wright LP, Philips MR (2006) Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras. J Lipid Res 47:883–891
Burridge K, Wennerberg K (2004) Rho and Rac take center stage. Cell 116:167–179
Mackay DJ, Hall A (1998) Rho GTPases. J Biol Chem 273:20685–20688
Wheeler AP, Ridley AJ (2004) Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 301:43–49
Roberts PJ, Mitin N, Keller PJ et al (2008) Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification. J Biol Chem 283:25150–25163
Dietrich LE, Ungermann C (2004) On the mechanism of protein palmitoylation. EMBO Rep 5:1053–1057
Smotrys JE, Linder ME (2004) Palmitoylation of intracellular signaling proteins: regulation and function. Annu Rev Biochem 73:559–587
Alm A, Nilsson SF (2009) Uveoscleral outflow—a review. Exp Eye Res 88:760–768
Tian B, Gabelt BT, Geiger B, Kaufman PL (2009) The role of the actomyosin system in regulating trabecular fluid outflow. Exp Eye Res 88:713–717
Ramachandran C, Satpathy M, Mehta D, Srinivas SP (2008) Forskolin induces myosin light chain dephosphorylation in bovine trabecular meshwork cells. Curr Eye Res 33:169–176
Shen X, Koga T, Park BC, SundarRaj N, Yue BY (2008) Rho GTPase and cAMP/protein kinase A signaling mediates myocilin-induced alterations in cultured human trabecular meshwork cells. J Biol Chem 283:603–612
Rao VP, Epstein DL (2007) Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma. BioDrugs 21:167–177
Honjo M, Tanihara H, Inatani M, Kido N, Sawamura T, Yue BY, Narumiya S, Honda Y (2001) Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci 42:137–144
Liu X, Hu Y, Filla MS, Gabelt BT, Peters DM, Brandt CR, Kaufman PL (2005) The effect of C3 transgene expression on actin and cellular adhesions in cultured human trabecular meshwork cells and on outflow facility in organ cultured monkey eyes. Mol Vis 11:1112–1121
Nakamura Y, Hirano S, Suzuki K, Seki K, Sagara T, Nishida T (2002) Signaling mechanism of TGF-beta1-induced collagen contraction mediated by bovine trabecular meshwork cells. Invest Ophthalmol Vis Sci 43:3465–3472
Rao PV, Deng P, Maddala R, Epstein DL, Li CY, Shimokawa H (2005) Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow. Mol Vis 11:288–297
Rao PV, Deng PF, Kumar J, Epstein DL (2001) Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci 42:1029–1037
Thieme H, Nuskovski M, Nass JU, Pleyer U, Strauss O, Wiederholt M (2000) Mediation of calcium-independent contraction in trabecular meshwork through protein kinase C and rho-A. Invest Ophthalmol Vis Sci 41:4240–4246
Liao JK, Seto M, Noma K (2007) Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 50:17–24
Tanihara H, Inatani M, Honjo M, Tokushige H, Azuma J, Araie M (2008) Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers. Arch Ophthalmol 126:309–315
Sever N, Song BL, Yabe D, Goldstein JL, Brown MS, DeBose-Boyd RA (2003) Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J Biol Chem 278:52479–52490
Holstein SA, Wohlford-Lenane CL, Hohl RJ (2002) Isoprenoids influence expression of Ras and Ras-related proteins. Biochemistry 41:13698–13704
Holstein SA, Wohlford-Lenane CL, Hohl RJ (2002) Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, AND RhoB. J Biol Chem 277:10678–10682
Von Zee CL, Richards MP, Bu P, Perlman JI, Stubbs EB (2009) Lovastatin increases RhoA and RhoB protein accumulation in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci
Von Zee CL, Stubbs EB Jr (2011) Geranylgeranylation facilitates proteasomal degradation of rho G-proteins in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 52:1676–1683
Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110:227–239
Laufs U, Liao JK (2000) Targeting Rho in cardiovascular disease. Circ Res 87:526–528
Adamson P, Marshall CJ, Hall A, Tilbrook PA (1992) Post-translational modifications of p21rho proteins. J Biol Chem 267:20033–20038
Armstrong SA, Hannah VC, Goldstein JL, Brown MS (1995) CAAX geranylgeranyl transferase transfers farnesyl as efficiently as geranylgeranyl to RhoB. J Biol Chem 270:7864–7868
Lebowitz PF, Du W, Prendergast GC (1997) Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcription. J Biol Chem 272:16093–16095
Allal C, Favre G, Couderc B, Salicio S, Sixou S, Hamilton AD, Sebti SM, Lajoie-Mazenc I, Pradines A (2000) RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription. J Biol Chem 275:31001–31008
Cole SL, Vassar R (2006) Isoprenoids and Alzheimer's disease: a complex relationship. Neurobiol Dis 22:209–222
Hooff GP, Wood WG, Muller WE, Eckert GP (2010) Isoprenoids, small GTPases and Alzheimer's disease. Biochim Biophys Acta 1801:896–905
Pac-Soo C, Lloyd DG, Vizcaychipi MP, Ma D (2011) Statins: the role in the treatment and prevention of Alzheimer's neurodegeneration. J Alzheimers Dis 27:1–10
Piau A, Nourhashemi F, Hein C, Caillaud C, Vellas B (2011) Progress in the development of new drugs in Alzheimer's disease. J Nutr Health Aging 15:45–57
Li L, Cao D, Kim H, Lester R, Fukuchi K (2006) Simvastatin enhances learning and memory independent of amyloid load in mice. Ann Neurol 60:729–739
Mans RA, Chowdhury N, Cao D, McMahon LL, Li L (2010) Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice. Neuroscience 166:435–444
Yue BY, Higginbotham EJ, Chang IL (1990) Ascorbic acid modulates the production of fibronectin and laminin by cells from an eye tissue-trabecular meshwork. Exp Cell Res 187:65–68
Laufs U, Endres M, Custodis F, Gertz K, Nickenig G, Liao JK, Bohm M (2000) Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 102:3104–3110
Correll CC, Ng L, Edwards PA (1994) Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 269:17390–17393
Stamatakis K, Cernuda-Morollon E, Hernandez-Perera O, Perez-Sala D (2002) Isoprenylation of RhoB is necessary for its degradation. A novel determinant in the complex regulation of RhoB expression by the mevalonate pathway. J Biol Chem 277:49389–49396
Pang IH, Shade DL, Clark AF, Steely HT, DeSantis L (1994) Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Curr Eye Res 13:51–63
Rolli-Derkinderen M, Sauzeau V, Boyer L, Lemichez E, Baron C, Henrion D, Loirand G, Pacaud P (2005) Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells. Circ Res 96:1152–1160
Liton PB, Gonzalez P, Epstein DL (2009) The role of proteolytic cellular systems in trabecular meshwork homeostasis. Exp Eye Res 88:724–728
Hanna J, Finley D (2007) A proteasome for all occasions. FEBS Lett 581:2854–2861
Boyer L, Turchi L, Desnues B et al (2006) CNF1-induced ubiquitylation and proteasome destruction of activated RhoA is impaired in Smurf1−/− cells. Mol Biol Cell 17:2489–2497
Chen Y, Yang Z, Meng M et al (2009) Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement. Mol Cell 35:841–855
Breusing N, Grune T (2008) Regulation of proteasome-mediated protein degradation during oxidative stress and aging. Biol Chem 389:203–209
Perez-Sala D, Boya P, Ramos I, Herrera M, Stamatakis K (2009) The C-terminal sequence of RhoB directs protein degradation through an endo-lysosomal pathway. PLoS One 4:e8117
Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsuura Y, Kaibuchi K (1997) Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 275:1308–1311
Waki M, Yoshida Y, Oka T, Azuma M (2001) Reduction of intraocular pressure by topical administration of an inhibitor of the Rho-associated protein kinase. Curr Eye Res 22:470–474
Song J, Deng PF, Stinnett SS, Epstein DL, Rao PV (2005) Effects of cholesterol-lowering statins on the aqueous humor outflow pathway. Invest Ophthalmol Vis Sci 46:2424–2432
Vittitow JL, Garg R, Rowlette LL, Epstein DL, O'Brien ET, Borras T (2002) Gene transfer of dominant-negative RhoA increases outflow facility in perfused human anterior segment cultures. Mol Vis 8:32–44
McGwin G Jr, McNeal S, Owsley C, Girkin C, Epstein D, Lee PP (2004) Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol 122:822–826
Acknowledgments
This work was supported, in part, by grants from the Department of Veterans Affairs (C3638R and B3756-F (EBS), Pre-Doctoral Associated Health Rehabilitation Research Fellowship and C7506M (CVZ)), the Illinois Society for the Prevention of Blindness, the Midwest Eye Banks, and the Richard A. Peritt Charitable Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stubbs, E.B., Von Zee, C.L. Prenylation of Rho G-Proteins: a Novel Mechanism Regulating Gene Expression and Protein Stability in Human Trabecular Meshwork Cells. Mol Neurobiol 46, 28–40 (2012). https://doi.org/10.1007/s12035-012-8249-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-012-8249-x